XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries

Molecular Carcinogenesis

Volumn 50, Issue 9, 2011, Pages 732-737

  Laantri, Nadia ^a,b   Jalbout, Majida ^c   Khyatti, Meriem ^a   Ayoub, Wided Ben ^d   Dahmoul, Sami ^e   Ayad, Messaoud ^f   Bedadra, Wided ^g   Abdoun, Meriem ^g   Mesli, Sarah ^f   Kandil, Mostafa ^b   Hamdi Cherif, Mokhtar ^g   Boualga, Kada ^f   Bouaouina, Noureddine ^e   Chouchane, Lotfi ^h   Benider, Abdellatif ⁱ   Ben Ayed, Farhat ^d   Goldgar, David ^j   Corbex, Marilys ^k  

^a Institut Pasteur du Maroc   (Morocco)

^b FACULTÉ DES SCIENCES   (Morocco)

^c HOLY SPIRIT UNIVERSITY OF KASLIK USEK   (Lebanon)

^d Association Tunisienne de Lutte Contre Le Cancer   (Tunisia)

^e FARHAT HACHED HOSPITAL   (Tunisia)

^f Centre Antic Cancer de Blida   (Algeria)

^g Setif 1 University   (Algeria)

^h UNIVERSITY OF MONASTIR   (Tunisia)

ⁱ IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

DNA repair; HOGG1; Nasopharyngeal carcinoma; North Africa; XRCC1

Indexed keywords

8 HYDROXYGUANINE; DNA; HUMAN 8 OXOGUANINE GLYCOSYLASE 1; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ADULT; ALGERIA; ALLELE; ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOROCCO; NASOPHARYNX CARCINOMA; NORTH AFRICA; PRIORITY JOURNAL; RURAL AREA; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA; URBAN AREA;

EID: 79960643843     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20754     Document Type: Article

References (33)

1. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: The role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 2003; 12: 689-698.
2. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: Correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2003; 2: 901-908.
3. Fan J, Otterlei M, Wong HK, Tomkinson AE, Wilson DM III. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 2004; 32: 2193-2201.
4. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin a variant frequency. Cancer Res 1999; 59: 2557-2561.
5. Yamane A, Kohno T, Ito K, et al. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 2004; 25: 1689-1694.
6. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1810-1818.
7. Li H, Hao X, Zhang W, Wei Q, Chen K. The hOGG1 Ser326Cys polymorphism and lung cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 1739-1745.
8. Yuan W, Xu L, Feng Y, et al. The hOGG1 Ser326Cys polymorphism and breast cancer risk: A meta-analysis. Breast Cancer Res Treat 2010; 122: 835-842.
9. Jiao X, Huang J, Wu S, et al. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int J Cancer 2007; 121: 501-505.
10. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002; 23: 1229-1234.
11. Cao Y, Miao XP, Huang MY, et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006; 6: 167.
12. Yang ZH, Du B, Wei YS, et al. Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol 2007; 26: 491-496.
13. Cho EY, Hildesheim A, Chen CJ, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003; 12: 1100-1104.
14. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from:.
15. Feng BJ, Khyatti M, Ben-Ayoub W, et al. Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer 2009; 101: 1207-1212.
16. Feng BJ, Jalbout M, Ayoub WB, et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer 2007; 121: 1550-1555.
17. Busson P, Keryer C, Ooka T, Corbex M. EBV-associated nasopharyngeal carcinomas: From epidemiology to virus-targeting strategies. Trends Microbiol 2004; 12: 356-360.
18. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 2005; 162: 925-942.
19. Kirk RL, Blake NM, Serjeantson S, Simons MJ, Chan SH. Genetic components in susceptibility to nasopharyngeal carcinoma. IARC Sci Publ 1978; 20: 283-297.
20. Tse KP, Su WH, Chang KP, et al. Genome-Wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 2009; 85: 194-203.
21. Bei JX, Li Y, Jia WH, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010; 42: 599-603.
22. Makni H, Daoud J, Ben Salah H, et al. HLA association with nasopharyngeal carcinoma in southern Tunisia. Mol Biol Rep 2010; 37: 2533-2539.
23. Li X, Ghandri N, Piancatelli D, et al. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians. J Transl Med 2007; 5: 22.
24. Dardari R, Khyatti M, Jouhadi H, et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 2001; 92: 294-297.
25. Ng CC, Yew PY, Puah SM, et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 2009; 54: 392-397.
26. Moullan N, Cox DG, Angele S, et al. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003; 12: 1168-1174.
27. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005; 97: 567-576.
28. Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 359-365.
29. David-Beabes GL, London SJ. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 2001; 34: 333-339.
30. Han J, Hankinson SE, De Vivo I, et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res 2003; 63: 8536-8541.
31. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 217-222.
32. Wikman H, Risch A, Klimek F, et al. hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a Caucasian population. Int J Cancer 2000; 88: 932-937.
33. Vogel U, Olsen A, Wallin H, et al. No association between OGG1 Ser326Cys and risk of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 1680-1681.